Skip to content
type1.science
N/A (device / behavioral)RecruitingNCT07745244

SiBionics GS3 CGM accuracy and safety in adults with T1D

Newly registered 15-day study comparing the GS3 real-time CGM with venous plasma reference measurements across glucose ranges in 36 adults with T1D.

Primary endpoints

  • System accuracy against reference venous plasma glucose over 15 days
  • Device-related safety over 15 days

Results so far

No results posted. The study is recruiting an estimated 36 participants in China and estimates primary completion in June 2027.